Catastrophic adult-onset Still's disease as a distinct life-threatening clinical subset: case-control study with dimension reduction analysis.

Acute respiratory failure Adult-onset Still’s disease Case–control study Clusters Cytokine storm Differential diagnosis Intensive care unit Reactive haemophagocytic syndrome Shock

Journal

Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438

Informations de publication

Date de publication:
11 10 2021
Historique:
received: 08 03 2021
accepted: 16 09 2021
entrez: 12 10 2021
pubmed: 13 10 2021
medline: 29 10 2021
Statut: epublish

Résumé

Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder. Diagnosing AOSD can be challenging, as disease presentation and clinical course are highly heterogeneous. For unclear reasons, a few patients develop life-threatening complications. Our objective was to determine whether these cases resulted from therapeutic delay or could represent a peculiar AOSD subset. We conducted a multicentre retrospective study of 20 AOSD patients with organ failure requiring intensive care unit admission and 41 control AOSD patients without organ failure. Clinico-biological data at hospital admission were explored using supervised analyses and unsupervised dimension reduction analysis (factor analysis of mixed data, FAMD). Disease duration before admission was shorter in patients with life-threatening AOSD (median, 10 vs 20 days, p = 0.007). Disease duration before AOSD therapy initiation also tended to be shorter (median, 24 vs 32 days, p = 0.068). Despite this shorter disease duration, FAMD, hierarchical clustering and univariate analyses showed that these patients exhibited distinctive characteristics at first presentation, including younger age; higher frequency of splenomegaly, liver, cardiac and/or lung involvement; less frequent arthralgia; and higher ferritin level. In multivariate analysis, 3 parameters predicted life-threatening complications: lack of arthralgia, younger age and shorter time between fever onset and hospitalisation. This study suggests that life-threatening complications of AOSD occur very early, in a peculiar subset, which we propose to name catastrophic adult-onset Still's disease (CAOSD). Its exact burden may be underestimated and remains to be clarified through large multicentre cohorts. Further studies are needed to identify red flags and define the optimal therapeutic strategy.

Identifiants

pubmed: 34635157
doi: 10.1186/s13075-021-02631-7
pii: 10.1186/s13075-021-02631-7
pmc: PMC8504015
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

256

Informations de copyright

© 2021. The Author(s).

Références

J Rheumatol. 2017 Jul;44(7):996-1003
pubmed: 28412707
Cytokine. 2013 Feb;61(2):345-8
pubmed: 23276493
Ann Rheum Dis. 1971 Mar;30(2):121-33
pubmed: 5315135
Ann Rheum Dis. 2004 May;63(5):605
pubmed: 15082500
Arthritis Res Ther. 2019 Feb 12;21(1):53
pubmed: 30755262
Medicine (Baltimore). 1991 Mar;70(2):118-36
pubmed: 2005777
Arthritis Rheum. 2010 Aug;62(8):2530-5
pubmed: 20506370
Expert Rev Clin Immunol. 2015 Jun;11(6):749-61
pubmed: 25948106
Arthritis Care Res (Hoboken). 2014 Apr;66(4):642-6
pubmed: 24124073
J Rheumatol. 2018 Jun;45(6):864-872
pubmed: 29657144
Ann Rheum Dis. 2006 May;65(5):564-72
pubmed: 16219707
Medicine (Baltimore). 2014 Mar;93(2):91-99
pubmed: 24646465
Medicine (Baltimore). 2015 Jan;94(4):e451
pubmed: 25634183
Clin Rheumatol. 2014 Mar;33(3):305-14
pubmed: 24435354
Expert Rev Clin Immunol. 2017 Nov;13(11):1089-1097
pubmed: 28870100
Ann Rheum Dis. 2018 Jun;77(6):840-847
pubmed: 29472362
Mod Rheumatol. 2015 May;25(3):393-400
pubmed: 25382730
Q J Med. 1986 Nov;61(235):1055-65
pubmed: 3659248
Clin Immunol. 2016 Aug;169:8-13
pubmed: 27263804
Arthritis Rheum. 2008 May;58(5):1505-15
pubmed: 18438814
Clin Rheumatol. 2016 Jul;35(7):1683-9
pubmed: 27207567
Nat Rev Rheumatol. 2018 Oct;14(10):603-618
pubmed: 30218025
Medicine (Baltimore). 2010 Jan;89(1):37-46
pubmed: 20075703
Semin Arthritis Rheum. 2016 Jun;45(6):711-6
pubmed: 26672682
Blood. 2019 Jun 6;133(23):2465-2477
pubmed: 30992265
Immunol Res. 2015 Feb;61(1-2):53-62
pubmed: 25388963
J Rheumatol. 1992 Mar;19(3):424-30
pubmed: 1578458
Crit Care. 2018 Apr 11;22(1):88
pubmed: 29642928
Medicine (Baltimore). 2002 May;81(3):194-200
pubmed: 11997716

Auteurs

Anaïs Wahbi (A)

Service de Médecine Interne, PHU3, Centre Hospitalier Universitaire de Nantes - Hôtel-Dieu, 1 Place Alexis Ricordeau, 44093, Nantes, France.

Benoît Tessoulin (B)

Service d'Hématologie, PHU1, CHU Hôtel-Dieu, 44093, Nantes, France.

Cédric Bretonnière (C)

Service de Pneumologie, PHU2, CHU de Nantes, 44093, Nantes, France.
UPRES EA 3826, Faculté de Médecine, Université de Nantes, 44035, Nantes, France.

Julien Boileau (J)

Service de Médecine, CH de Morlaix, 29672, Morlaix, France.

Dorothée Carpentier (D)

Service de Réanimation Médicale, CHU de Rouen, 76031, Rouen, France.

Olivier Decaux (O)

Service de Médecine Interne, CHU de Rennes, 35033, Rennes, France.

Laurence Fardet (L)

Service de Dermatologie, Hôpital Henri Mondor, 94000, Créteil, France.

Guillaume Geri (G)

Service de Réanimation Médicale, CHU Cochin, AP-HP, 75012, Paris, France.

Pascal Godmer (P)

CH Bretagne-Atlantique, 56000, Vannes, France.

Cécile Goujard (C)

Service de Médecine Interne, CHU Bicêtre, AP-HP, 94270, Kremlin-Bicêtre, France.

Hervé Maisonneuve (H)

Service de Médecine Interne, CHD Vendée, 85925, La Roche-sur-Yon, France.

Arnaud Mari (A)

Service de Réanimation, Hôpital Yves Le Foll, 22000, St Brieuc, France.

Jacques Pouchot (J)

Service de Médecine Interne, Hôpital Européen Georges Pompidou, AP-HP, 75908, Paris, France.

Jean-Marc Ziza (JM)

Service de Médecine Interne-Rhumatologie, Groupe Hospitalier Diaconesses-Croix-Saint-Simon, 75020, Paris, France.

Sophie Georgin-Lavialle (S)

Service de Médecine Interne, CHU Tenon, AP-HP, 75020, Paris, France.

Mohamed Hamidou (M)

Service de Médecine Interne, PHU3, Centre Hospitalier Universitaire de Nantes - Hôtel-Dieu, 1 Place Alexis Ricordeau, 44093, Nantes, France.

Antoine Néel (A)

Service de Médecine Interne, PHU3, Centre Hospitalier Universitaire de Nantes - Hôtel-Dieu, 1 Place Alexis Ricordeau, 44093, Nantes, France. antoine.neel@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH